发明名称 Eimmunotherapy for immune suppressed patients
摘要 The present invention provides compositions of a natural cytokine mixture (NCM) for treating a cellular immunodeficiency characterized by T lymphocytopenia, one or more dendritic cell functional defects such as those associated with lymph node sinus histiocytosis, and/or one or more monocyte functional defects such as those associated with a negative skin test to NCM. The invention includes methods of treating these cellular immunodeficiencies using the NCM of the invention. The compositions and methods are useful in the treatment of diseases associated with cellular immunodeficiencies such as cancer. Also provided are compositions and methods for reversing tumor-induced immune suppression comprising a chemical inhibitor and a non-steroidal anti-inflammatory drug (NSAID). The invention also provides a diagnostic skin test comprising NCM for predicting treatment outcome in cancer patients.
申请公布号 AU2007254022(A1) 申请公布日期 2007.11.29
申请号 AU20070254022 申请日期 2007.03.09
申请人 IRX THERAPEUTICS, INC. 发明人 PAUL NAYLOR;JOHN W. HADDEN
分类号 A61K48/00 主分类号 A61K48/00
代理机构 代理人
主权项
地址